HOME ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE STORY OF OUR FIRM SEARCH

Clinical Trials for Mesothelioma Patients: Cisplatin, Imatinib Mesylate, and Pemetrexed Study

Read about a current clinical trial study being conducted to study the effects of Cisplatin, Imatinib Mesylate, and Pemetrexed or patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, this study is only being conducted in Lille, France.

Requisite Conditions:

Mesothelioma

Interventions:

Drugs: Cisplatin; Imatinib Mesylate; Pemetrexed

Study Phase, Type and Design:
Phase I Interventional; Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study

Official Title:
Phase I Trial of Cisplatin, Pemetrexed, and Imatinib Mesylate in Unresectable or Metastatic Malignant Mesothelioma

Courtesy of a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

CONTACT WEITZ & LUXENBERG FOR A FREE LEGAL EVALUATION OF YOUR CASE

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

TABLE OF CONTENTS
Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Imatinib Mesylate trial for mesothelioma patients
Outcomes of Imatinib against mesothelioma cancer
Recruitment data to test Imatinib on mesothelioma
Inclusion standard in Imatinib mesothelioma trial
Exclusion standard in Imatinib mesothelioma trial
Contact info for Imatinib mesothelioma study


RETURN BACK TO
Mesothelioma
Symptoms, Stages, Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma
see also:

Inclusion standard in Imatinib mesothelioma trial Inclusion criteria to treat mesothelioma patients with Imatinib
Patient inclusion criteria for Imatinib mesothelioma clinical trial

Imatinib Mesylate trial for mesothelioma patients Clinical trial of Imatinib Mesylate therapy for mesothelioma patients
Imatinib Mesylate may slow cancer cell growth in mesothelioma patients

Current Imatinib therapy for mesothelioma patients Current clinical trial of Imatinib therapy for mesothelioma patients
Imatinib may inhibit cancer cell growth in current mesothelioma test